Zura Bio Limited
ZURA
$5.78
-$0.35-5.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -7.94% | 22.47% | 14.83% | -43.03% | 50.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.34% | 32.43% | 17.03% | 1.04% | 53.60% |
| Operating Income | -62.34% | -32.43% | -17.03% | -1.04% | -53.60% |
| Income Before Tax | -64.98% | -38.88% | -26.06% | 12.86% | -54.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -64.47% | -38.88% | -26.06% | 12.86% | -54.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.47% | -38.88% | -26.06% | 12.86% | -54.84% |
| EBIT | -62.34% | -32.43% | -17.03% | -1.04% | -53.60% |
| EBITDA | -62.35% | -32.41% | -16.97% | -0.98% | -53.51% |
| EPS Basic | -22.29% | -15.03% | -386.33% | 19.34% | -0.36% |
| Normalized Basic EPS | -22.64% | -15.00% | -20.94% | 19.51% | -23.11% |
| EPS Diluted | -22.29% | -15.03% | -386.33% | 19.34% | -0.36% |
| Normalized Diluted EPS | -22.64% | -15.00% | -20.94% | 19.51% | -23.11% |
| Average Basic Shares Outstanding | 34.48% | 20.72% | 4.25% | 8.28% | 25.81% |
| Average Diluted Shares Outstanding | 34.48% | 20.72% | 4.25% | 8.28% | 25.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |